Under construction – not a live service
Sign in
Taking people in SingaporeNo phase

Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

Key facts

Where
Singapore, SingaporeSee the site

Where in Singapore

  • National Cancer Centre SingaporeSingapore, SingaporeTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National Cancer Centre, Singapore
Trial code
NCT02806388
Record updated
13 May 2026
Original description
This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.Read full original descriptionShow less

This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.

Inclusion: Confirmed histological diagnosis of solid tumor; Suitable for systematic treatment and clinical trials; ECOG (Eastern cooperative oncology group) performance status < 2; Able to provide tumor tissue for molecular profiling; Able to understand and sign the informed consent form.

Exclusion: None.

ClinicalTrials.gov NCT02806388